Sentences with phrase «says vaccine researcher»

In the world of vaccine development, 3 1/2 months from design to injection is «warp speed,» says vaccine researcher Nelson Michael of the Walter Reed Army Institute of Research in Silver Spring, Md..

Not exact matches

Researchers have developed a vaccine that works in mice and rats, but scientists say this vaccine is still in the early stages.

«If they could figure out a way to streamline, it would be a lot better,» said Kim Janda, a professor of chemistry at the Scripps Research Institute in La Jolla, California, who leads a team of researchers developing a vaccine that would prevent fentanyl overdoses by keeping the drug from reaching the brain.

There may also be other applications from this work, they say: Researchers could similarly take other viruses apart in the lab, scour them for important mutations and create vaccines against a plethora of other infections.

The message that the vaccine prevents cancer isn't getting out there, researchers say.

«HPV vaccine, riskier sexual activity not linked, Canadian researchers say.»

The researchers say public health authorities must address people's concerns and debunk unscientific claims if they are to ensure a vaccine is effective.

«Although HPV vaccine has been around for more than a decade, the uptake of the vaccine has been less than ideal in many places, including in high - resource countries such as the United States,» said Silvina Arrossi, PhD, co-chair of the Expert Panel that developed the guideline and an official and researcher at the Instituto Nacional del Cancer in Buenos Aires, Argentina.

«Funders don't control the composition of the committee, and they don't meet with the committee,» says Harvard public - health researcher Marie McCormick, who chaired the IOM vaccine - safety committee in question.

If researchers could induce antibodies with long HCDR3s in humans, «then that could be the basis of getting a vaccine to work,» Smider says.

«In the last few years, we've decided that it's probably not a good idea to produce [vaccines] in food products,» says Hugh Mason, an Arizona State University vaccine researcher who helped develop the first edible vaccine.

Studies that compare flu alterations in multiple people won't immediately tell researchers how to design vaccines, she says, but could point to parts of the virus for further investigation.

The researchers said it was important to test their candidate vaccines on the Makona strain to ensure that even small differences between the strains didn't impact the effectiveness of the vaccine.

The genetic code also holds clues to Chlamydia's surface proteins, which Stephens says should give researchers new targets for vaccines, diagnostic tests, and drugs.

Many Ebola researchers say they, too, would eagerly try the antibodies — or one of the promising candidate drugs, or an experimental Ebola vaccine.

Crotty says the ability to measure Tfh cells in the blood will assist AIDS vaccine researchers by serving as an indicator of antibody response.

And questions abound, many from researchers and developers who say they need recent virus samples to produce more efficient vaccines.

And no drug or vaccine is going to work once patients are very ill, says Ebola researcher Thomas Geisbert of the University of Texas Medical Branch in Galveston; if patients seek care too late, that could create the mistaken impression that the interventions are useless.

The same strategy might aid efforts to design vaccines against other viruses, researchers said.

Researchers must be prepared to construct new vaccines to deal with emerging new strains, says Mooi.

But other diarrhea researchers say that the vaccine's effectiveness in Venezuela doesn't mean that it will work everywhere.

Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.

A new type of easily customizable vaccine can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks, say researchers.

Dr Welaga says that researchers should consider testing the effect of measles vaccines and other routine vaccines on all - cause mortality in randomized trials.

With this approach if validated for other vaccines, we only need to wait for a week,» says researcher Ali Harandi, who heads the participation of Sahlgrenska Academy and University of Gothenburg in the project.

These findings could lead to the first broadly effective ebolavirus therapies and vaccines, say researchers.

«Dengue vaccine could increase or worsen dengue in some settings: Researchers say health officials must be careful about where vaccine is used.»

A new HCV infection is effectively treated with direct - acting antiviral drugs, but the researchers say a preventive vaccine is needed to control what they call an HCV pandemic because as many as 50 percent of people infected are unaware that they carry the virus, putting others at risk of infection.

Of more than 50 therapeutic vaccine trials so far, this is the first one that has bolstered the immune system in a «meaningful» way, says Steven Deeks, an HIV / AIDS clinician and researcher at the University of California, San Francisco, who is «cautiously optimistic» that the data will inspire others to study the approach.

Frieden said the halt has raised concerns from researchers working on drug - resistant tuberculosis, the Ebola outbreak in Africa, and preparations for next season's influenza vaccine.

«That is super solid protection,» says CJ Peters, a vaccine researcher at University of Texas, Galveston.

Also, he says, the study shows that high - risk groups, such as researchers and lab technicians working with West Nile, should consider getting a JE shot as long as there's no specific West Nile vaccine.

Sanaria's vaccine aims for 90 % protection or even higher, says CEO Stephen Hoffman, a former U.S. Navy researcher who started the company in his kitchen 8 years ago.

This is why it is so difficult for humans to mount an effective immune response and why it is challenging for researchers to develop vaccines targeting the HIV envelope proteins,» Dr. Blanchard says.

Adrian Hill, a vaccine researcher at the University of Oxford in the United Kingdom, says the experiments support the idea that vaccines helped make Marek's disease deadlier, but don't prove it.

The vaccine also has potential to be administered to developing chicks in eggs, resulting in offspring being automatically vaccinated for the diseases, said Wenjun Ma, Kansas State University assistant professor of diagnostic medicine and pathobiology and one of the researchers involved.

The results are «very encouraging,» says Mariano Esteban, a poxvirus researcher at the Universidad Autónoma in Madrid, Spain, adding that they could prelude a safer generation of smallpox vaccines for humans to replace the old standbys from the smallpox eradication era.

In the real world, a field like the AIDS vaccine one has so much failure that when researchers see positive data they say, Eureka!

The studies support the concept of using natural exposure in combination with malaria - fighting drugs to help people build up protection against disease, says malaria vaccine researcher Robert Sauerwein of the Radboud University Nijmegen Medical Center in the Netherlands.

Using both DNA and protein vaccines resulted in more diverse antibodies, the researchers say.

The vaccine is a «very novel approach for the treatment of obesity,» says Matthias Tschöp, an obesity researcher at the University of Cincinnati in Ohio.

Doctors could potentially use the pneumonia prediction score to encourage older adults to get the pneumococcal vaccine that protects against pneumonia, as well as to counsel at - risk individuals about positive behavioral changes such as quitting smoking, said the researchers.

The vaccine, a DNA vaccine, is safer and more effective against Zika virus and could offer more affordable long - term protection, researchers said.

Only one vaccine has been licensed, and neither it nor any others in development today will be 100 percent effective against malaria infection, said lead researcher José A. Stoute, associate professor of medicine and microbiology and immunology.

The researchers say the results warrant further development of neoantigen vaccines, both alone and in combination with other immunotherapy weapons such as checkpoint inhibitors.

Meanwhile, researchers are already finding new ways to enhance the vaccine's effectiveness, he said.

«When the SSGCID solves protein structures, it lays the foundation for researchers at CID Research and around the world to find new drugs, therapies and vaccine candidates for diseases that kill thousands each year,» said Myler.

Whitehead and the other researchers said that in the case of dengue, the testing was warranted because they knew that the vaccine appeared to be effective at preventing dengue 1, 3 and 4 viruses through previous testing but needed to learn more about its impact on dengue 2 before proceeding to larger trials that could take three to 10 years and cost tens of millions of dollars.

Leaders of several of the nation's top science organizations say they've been shunned by the Trump administration and are alarmed by signs that the administration will muzzle government researchers and reject the scientific evidence that informs such critical issues as vaccine safety and climate change.

There is no drug to treat Zika or a vaccine to prevent it, although Fauci said researchers are working on the latter.